Warning letter
Hunterdon Medical Center: warning letter of May 3, 2004
FDA warning letter UCM146374 · New Jersey District Office
Key facts
| Reference number | UCM146374 |
|---|---|
| Company | Hunterdon Medical Center |
| Subject | Good Manufacturing Practices for Blood & Blood Components/Adulterated |
| Issue date | May 3, 2004 |
| Posted date | May 3, 2004 |
| Issuing office | New Jersey District Office |
| Product type | Unknown |
| CFR sections cited | 606.171, 640.4, 606.60(a), 606.100(c), 606.140(a), 606.100(b), 606.160(e) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: